Specialized Training for Physicians Interested in BMT and Immunotherapies
This intensive one-year fellowship is designed to prepare physicians for academic careers focused on transplantation and cellular therapy. Our program started in the late 1960s with Nobel prize winner, E. Donnall Thomas, and his team of transplant physicians and clinical staff, who discovered a way to treat advanced leukemia by eradicating malignant white blood cells in the bone marrow using high doses of chemotherapy and radiation, and then replacing them with healthy donor cells. We now have 60 clinical faculty members at Fred Hutch and the University of Washington who specialize in transplantation and cellular therapy and serve as mentors to trainees from around the world.
Program Overview
The BMT and Immunotherapy fellowship is an intense, year-long program to prepare hematology-oncology physicians to become adept in blood and marrow transplantation (BMT) and immunotherapy (IMTX) services.
You will have the opportunity to work with world renowned faculty who are on the cutting edge of novel treatments for malignant and non-malignant diseases. The fellow will rotate through outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up) and IMTX services, and initially function as a primary care provider with increasing levels of patient care responsibility over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available to participate in research projects.
The application system is currently accepting materials for the July 2025 - June 2026 academic year.
Fellowship Co-Directors
Marco Mielcarek, M.D.
Professor
Clinical Research Division, Fred Hutch
Medical Director
Adult Blood and Marrow Transplantation,
Fred Hutch
Mazyar Shadman, MD, MPH
Associate Professor
Clinical Research Division, Fred Hutch
Medical Director
Cellular Immunotherapy and the Bezos Family Immunotherapy Clinic
Innovators Network Endowed Chair
Committee Members
Stephanie Lee, M.D., M.P.H.
Section Head, Hematologic Malignancies
Clinical Research Division, Fred Hutch
Professor and Associate Director
Clinical Research Division, Fred Hutch
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, Fred Hutch
Masumi Ueda Oshima, M.D., M.A.
Associate Professor Clinical Research Division, Fred Hutch
Associate Professor Division of Medical Oncology University of Washington School of Medicine
Assistant Medical Director Inpatient Blood and Marrow Transplantation
Fred Hutch
Geoff Hill, M.D., F.R.A.C.P., F.R.C.P.A.
Senior Vice President and Director
Translational Sciences and Therapeutics Division, Fred Hutch
Director of Hematopoietic Stem Cell Transplantation
Fred Hutch
José Carreras / E. Donnall Thomas Endowed Chair for Cancer Research, Fred Hutch
Application Instructions
The application system is currently accepting materials for the July 2025 - June 2026 academic year.
- C.V.
- Statement of clinical and research interests
- Personal statement outlining your interests in the fellowship program
- A diversity, inclusion and mentoring statement
- Contact information for at least three professional references (including your hem/onc fellowship director)
- The ideal candidate should have an interest in hematopoietic cell transplantation and/or immunotherapy and should have completed a fellowship in hematology or hematology-oncology.
- All applicants must have a medical doctorate (or foreign equivalent) and be board eligible/certified.
- US graduates must be ABIM board eligible/certified in Hematology and/or Oncology.
- In order to be eligible for sponsorship for an H-1B visa, graduates of foreign medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) and be ECFMG certified.
We believe that the diversity of our fellows, residents, medical students, staff and faculty is a fundamental element of our ability to ensure that all our patients and families receive the highest-quality care – no matter their race, ethnicity, language, literacy, age, gender, gender identity, sexual orientation, religion, disability or finances. Our objective is to create a community that encourages participation and connection, and that values and includes each individual's unique contribution, in every aspect of our mission and practice.
Questions about the program can be sent to:
Anne Nguyen
Project Manager, Practice Plan
Medical Staff Office